IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 253 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,574,000 | -28.6% | 144,461 | +4.7% | 0.25% | -34.8% |
| Q4 2020 | $6,402,000 | +23.3% | 137,981 | -12.5% | 0.38% | +9.1% |
| Q3 2020 | $5,193,000 | +40.8% | 157,751 | +17.4% | 0.35% | +31.1% |
| Q2 2020 | $3,689,000 | +4.1% | 134,391 | +13.5% | 0.27% | -7.3% |
| Q1 2020 | $3,545,000 | -7.4% | 118,421 | -14.4% | 0.29% | +8.7% |
| Q4 2019 | $3,829,000 | +39.9% | 138,325 | -8.0% | 0.26% | +32.5% |
| Q3 2019 | $2,737,000 | -23.2% | 150,410 | +3.5% | 0.20% | -20.6% |
| Q2 2019 | $3,565,000 | -3.6% | 145,380 | -62.6% | 0.25% | +9.1% |
| Q1 2019 | $3,699,000 | -27.6% | 388,995 | -14.4% | 0.23% | -29.1% |
| Q3 2018 | $5,111,000 | – | 454,295 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |